{"id":30107,"date":"2024-12-30T21:35:22","date_gmt":"2024-12-30T20:35:22","guid":{"rendered":"https:\/\/www.mylav.net\/?p=30107"},"modified":"2024-12-30T21:35:22","modified_gmt":"2024-12-30T20:35:22","slug":"nouvelle-formule-sanguine-mylav-mode-demploi","status":"publish","type":"post","link":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/","title":{"rendered":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Le rapport sur l&rsquo;h\u00e9mogramme MYLAV change d&rsquo;apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens. L\u2019objectif est de simplifier les informations pr\u00e9sentes dans l&rsquo;h\u00e9mogramme pour les rendre plus claires et facilement exploitables. Voici les principaux changements.<\/span><\/p>\n<p><b>La technologie utilis\u00e9e<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Nous passons de l\u2019ancien syst\u00e8me ADVIA-Siemens au plus r\u00e9cent <\/span><b>Sysmex<\/b><span style=\"font-weight: 400;\">, un instrument combinant la technologie d\u2019imp\u00e9dance \u00e9lectrique avec la technologie laser.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La majorit\u00e9 des donn\u00e9es classiques d\u2019une analyse sanguine restent inchang\u00e9es, mais le nouveau rapport inclut quelques fonctionnalit\u00e9s suppl\u00e9mentaires, d\u00e9taill\u00e9es ci-dessous par lign\u00e9e cellulaire.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-30108 size-full aligncenter\" src=\"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png\" alt=\"\" width=\"675\" height=\"722\" \/><\/p>\n<p><b>\u00c9rythrocytes<\/b><\/p>\n<p><span style=\"font-weight: 400;\">La combinaison des technologies d\u2019imp\u00e9dance et de lecture optique permet de conserver toutes les informations pr\u00e9sentes dans l\u2019ancien rapport. Cependant, certains sigles ont \u00e9t\u00e9 modifi\u00e9s :<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Le nombre d\u2019\u00e9rythrocytes (RBC), l\u2019h\u00e9matocrite (HCT), la concentration d\u2019h\u00e9moglobine totale (HGB) et la largeur de distribution des volumes globulaires rouges (RDW) restent inchang\u00e9s.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">L\u2019h\u00e9moglobine intra\u00e9rythrocytaire (pr\u00e9c\u00e9demment \u00ab\u00a0HGB cellulaire\u00a0\u00bb) est d\u00e9sormais d\u00e9sign\u00e9e <\/span><b>HGB-O<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Les indices \u00e9rythrocytaires classiques (MCV, MCH, MCHC) restent inchang\u00e9s.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">La teneur moyenne en h\u00e9moglobine (pr\u00e9c\u00e9demment \u00ab\u00a0CH\u00a0\u00bb) est d\u00e9sormais appel\u00e9e <\/span><b>RBC-He<\/b><span style=\"font-weight: 400;\">, et la concentration moyenne en h\u00e9moglobine (pr\u00e9c\u00e9demment \u00ab\u00a0CHCM\u00a0\u00bb) devient <\/span><b>MCHC-O<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Le syst\u00e8me Sysmex permet une quantification pr\u00e9cise des globules rouges nucl\u00e9\u00e9s (nRBC), avec deux nouvelles valeurs rapport\u00e9es :\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Le nombre d\u2019\u00e9rythrocytes nucl\u00e9\u00e9s pour 100 leucocytes (nRBC\/100 WBC).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">La valeur absolue des \u00e9rythrocytes nucl\u00e9\u00e9s (nRBC x 10\u00b3\/\u00b5L).<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><b>R\u00e9ticulocytes<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Le profil des r\u00e9ticulocytes a \u00e9t\u00e9 simplifi\u00e9 pour ne conserver que les param\u00e8tres les plus cliniquement pertinents, d\u00e9j\u00e0 pr\u00e9sents dans l\u2019ancien rapport :<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Le pourcentage et le nombre absolu de r\u00e9ticulocytes (RET).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Les pourcentages de r\u00e9ticulocytes faiblement fluorescents (L-RET), moyennement fluorescents (M-RET) et fortement fluorescents (H-RET), correspondant respectivement aux r\u00e9ticulocytes matures, moyennement immatures et tr\u00e8s immatures. Les deux derni\u00e8res cat\u00e9gories sont regroup\u00e9es sous la valeur globale des r\u00e9ticulocytes immatures (IRF), comme dans l\u2019ancien rapport.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">La teneur en h\u00e9moglobine des r\u00e9ticulocytes, auparavant exprim\u00e9e en <\/span><b>CHr<\/b><span style=\"font-weight: 400;\">, est d\u00e9sormais indiqu\u00e9e sous la forme <\/span><b>Ret-He<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Comme pr\u00e9c\u00e9demment, le pourcentage corrig\u00e9 des r\u00e9ticulocytes est calcul\u00e9 en fonction de l\u2019h\u00e9matocrite et de l\u2019indice de production des r\u00e9ticulocytes (RPI).<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><b>Leucocytes<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Les donn\u00e9es relatives au leucogramme restent inchang\u00e9es par rapport \u00e0 l\u2019ancien rapport :<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Le nombre total de leucocytes (WBC).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Le nombre et le pourcentage des diff\u00e9rentes populations leucocytaires (neutrophiles, \u00e9osinophiles, basophiles, lymphocytes et monocytes, incluant les band-cells si pr\u00e9sents).<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Cependant, il est important de noter que le nombre total de leucocytes correspond d\u00e9sormais \u00e0 celui pr\u00e9c\u00e9demment corrig\u00e9 (WBC corr.). Cette correction, qui d\u00e9pendait du nombre de globules rouges nucl\u00e9\u00e9s observ\u00e9s au microscope, n\u2019est plus n\u00e9cessaire gr\u00e2ce au Sysmex, qui les compte s\u00e9par\u00e9ment.<\/span><\/p>\n<p><b>Plaquettes<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Pour les plaquettes, seules les donn\u00e9es les plus cliniquement pertinentes sont incluses, comme dans l\u2019ancien rapport :<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Nombre de plaquettes (PLT).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Volume plaquettaire moyen (MPV).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Taux plaquettaire (PCT).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Fraction de grosses plaquettes (P-LCR).<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Nouvelle fonctionnalit\u00e9 : chez les animaux thrombocytop\u00e9niques, le pourcentage de plaquettes immatures (<\/span><b>IPF<\/b><span style=\"font-weight: 400;\">) est d\u00e9sormais inclus. Ce param\u00e8tre permet de distinguer une thrombocytop\u00e9nie p\u00e9riph\u00e9rique (augmentation de l\u2019IPF) d\u2019une thrombocytop\u00e9nie d\u2019origine m\u00e9dullaire (IPF normal ou r\u00e9duit).<\/span><\/p>\n<p><b>Observations morphologiques<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Les anomalies morphologiques des populations cellulaires sanguines, observ\u00e9es au microscope, continuent d\u2019\u00eatre signal\u00e9es dans le rapport. Cela inclut \u00e9galement tout autre r\u00e9sultat pathologique d\u00e9tect\u00e9 sur le frottis sanguin, comme la pr\u00e9sence d\u2019agents infectieux.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">Bibliographie<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">1: Guerlin M, Granat F, Grebert M, Braun JP, Geffr\u00e9 A, Bourg\u00e8s-Abella N, Trumel C. Validation of the Sysmex XN-V hematology analyzer for feline specimens. Vet Clin Pathol. 2024 Sep;53(3):294-308.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">2: Perez-Ecija A, Martinez C, Fernandez-Casta\u00f1er J, Mendoza FJ.\u00a0Utility of immature platelet fraction in the Sysmex XN-1000V for the differential diagnosis of central and peripheral thrombocytopenia in dogs and cats. J Vet Intern Med. 2024 May-Jun;38(3):1512-1519.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">3: Ginders J, Stirn M, Novacco M, Hofmann-Lehmann R, Riond B. Validation of the Sysmex XN-V Automated Nucleated Red Blood Cell Enumeration for Canine and Feline EDTA-Anticoagulated Blood. Animals (Basel). 2024 Jan 30;14(3):455.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">4: Perez-Ecija A, Martinez C, Fernandez-Casta\u00f1er J, Mendoza FJ.\u00a0The Immature Reticulocyte Fraction (IRF) in the Sysmex XN-1000V Analyzer Can Differentiate between Causes of Regenerative and Non-Regenerative Anemia in Dogs and Cats. Animals (Basel). 2024 Jan 22;14(2):349.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">5: Jornet-Rius O, Mesalles-Naranjo M, Pastor J. Performance of the Sysmex XN-V hematology analyzer in determining the immature platelet fraction in dogs: A preliminary study and reference values. Vet Clin Pathol. 2023 Sep;52(3):433-442.<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">6: Grebert M, Granat F, Braun JP, Leroy Q, Bourg\u00e8s-Abella N, Trumel C. Validation of the Sysmex XN-V hematology analyzer for canine specimens. Vet Clin Pathol. 2021 Jun;50(2):184-197.<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><b>Saverio Paltrinieri,\u00a0<\/b><span style=\"font-weight: 400;\">DMV, EBVS European Specialist in Veterinary Clinical Pathology (Dipl. ECVCP); Expert MYLAV en Pathologie Clinique<\/span><\/p>\n<p><b>Ugo Bonfanti,\u00a0<\/b><span style=\"font-weight: 400;\">DMV, EBVS European Specialist in Veterinary Clinical Pathology (Dipl. ECVCP); Directeur medical de MYLAV\u00a0<\/span><\/p>\n<p><b>Walter Bertazzolo,\u00a0<\/b><span style=\"font-weight: 400;\">DMV, EBVS European Specialist in Veterinary Clinical Pathology (Dipl. ECVCP); Directeur scientifique de MYLAV<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le rapport sur l&rsquo;h\u00e9mogramme MYLAV change d&rsquo;apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1120],"tags":[],"class_list":["post-30107","post","type-post","status-publish","format-standard","hentry","category-hematologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav<\/title>\n<meta name=\"description\" content=\"Le rapport sur l&#039;h\u00e9mogramme MYLAV change d&#039;apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav\" \/>\n<meta property=\"og:description\" content=\"Le rapport sur l&#039;h\u00e9mogramme MYLAV change d&#039;apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/\" \/>\n<meta property=\"og:site_name\" content=\"MyLav\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/laboratoriolavallonea\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-30T20:35:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"675\" \/>\n\t<meta property=\"og:image:height\" content=\"722\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Omar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Omar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/\"},\"author\":{\"name\":\"Omar\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#\\\/schema\\\/person\\\/3bcd23eb1fe4bd11ab10ce46f81f3d0d\"},\"headline\":\"Nouvelle formule sanguine MYLAV : mode d\u2019emploi\",\"datePublished\":\"2024-12-30T20:35:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/\"},\"wordCount\":887,\"publisher\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Immagine1.png\",\"articleSection\":[\"H\u00e9matologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/\",\"url\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/\",\"name\":\"Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Immagine1.png\",\"datePublished\":\"2024-12-30T20:35:22+00:00\",\"description\":\"Le rapport sur l'h\u00e9mogramme MYLAV change d'apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Immagine1.png\",\"contentUrl\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Immagine1.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/hematologie\\\/nouvelle-formule-sanguine-mylav-mode-demploi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelle formule sanguine MYLAV : mode d\u2019emploi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/\",\"name\":\"MyLav\",\"description\":\"vicini al tuo veterinario, vicini alla tua famiglia\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#organization\",\"name\":\"MyLav\",\"alternateName\":\"MyLav\",\"url\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/logo_mylav.svg\",\"contentUrl\":\"https:\\\/\\\/www.mylav.net\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/logo_mylav.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"MyLav\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/laboratoriolavallonea\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/mylav\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCPinPLKBkenJ_QlDKxXXjCA\",\"https:\\\/\\\/open.spotify.com\\\/show\\\/42D6N8rL6JzgjCfVnroMzp\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.mylav.net\\\/fr\\\/#\\\/schema\\\/person\\\/3bcd23eb1fe4bd11ab10ce46f81f3d0d\",\"name\":\"Omar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g\",\"caption\":\"Omar\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav","description":"Le rapport sur l'h\u00e9mogramme MYLAV change d'apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav","og_description":"Le rapport sur l'h\u00e9mogramme MYLAV change d'apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.","og_url":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/","og_site_name":"MyLav","article_publisher":"https:\/\/www.facebook.com\/laboratoriolavallonea\/","article_published_time":"2024-12-30T20:35:22+00:00","og_image":[{"width":675,"height":722,"url":"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png","type":"image\/png"}],"author":"Omar","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Omar","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#article","isPartOf":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/"},"author":{"name":"Omar","@id":"https:\/\/www.mylav.net\/fr\/#\/schema\/person\/3bcd23eb1fe4bd11ab10ce46f81f3d0d"},"headline":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi","datePublished":"2024-12-30T20:35:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/"},"wordCount":887,"publisher":{"@id":"https:\/\/www.mylav.net\/fr\/#organization"},"image":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png","articleSection":["H\u00e9matologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/","url":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/","name":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi - MyLav","isPartOf":{"@id":"https:\/\/www.mylav.net\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#primaryimage"},"image":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png","datePublished":"2024-12-30T20:35:22+00:00","description":"Le rapport sur l'h\u00e9mogramme MYLAV change d'apparence. Cette \u00e9volution r\u00e9pond \u00e0 la n\u00e9cessit\u00e9 de s\u2019adapter aux technologies les plus r\u00e9centes tout en r\u00e9pondant aux attentes des cliniciens.","breadcrumb":{"@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#primaryimage","url":"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png","contentUrl":"https:\/\/www.mylav.net\/wp-content\/uploads\/2024\/12\/Immagine1.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.mylav.net\/fr\/hematologie\/nouvelle-formule-sanguine-mylav-mode-demploi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mylav.net\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvelle formule sanguine MYLAV : mode d\u2019emploi"}]},{"@type":"WebSite","@id":"https:\/\/www.mylav.net\/fr\/#website","url":"https:\/\/www.mylav.net\/fr\/","name":"MyLav","description":"vicini al tuo veterinario, vicini alla tua famiglia","publisher":{"@id":"https:\/\/www.mylav.net\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mylav.net\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.mylav.net\/fr\/#organization","name":"MyLav","alternateName":"MyLav","url":"https:\/\/www.mylav.net\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mylav.net\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.mylav.net\/wp-content\/uploads\/2019\/02\/logo_mylav.svg","contentUrl":"https:\/\/www.mylav.net\/wp-content\/uploads\/2019\/02\/logo_mylav.svg","width":"1024","height":"1024","caption":"MyLav"},"image":{"@id":"https:\/\/www.mylav.net\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/laboratoriolavallonea\/","https:\/\/www.linkedin.com\/company\/mylav\/","https:\/\/www.youtube.com\/channel\/UCPinPLKBkenJ_QlDKxXXjCA","https:\/\/open.spotify.com\/show\/42D6N8rL6JzgjCfVnroMzp"]},{"@type":"Person","@id":"https:\/\/www.mylav.net\/fr\/#\/schema\/person\/3bcd23eb1fe4bd11ab10ce46f81f3d0d","name":"Omar","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9747389c2044f754dd3ef5bdd0e0829fc994e0405b417eb7fb24d7d11f0bd4c0?s=96&d=mm&r=g","caption":"Omar"}}]}},"_links":{"self":[{"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/posts\/30107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/comments?post=30107"}],"version-history":[{"count":1,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/posts\/30107\/revisions"}],"predecessor-version":[{"id":30115,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/posts\/30107\/revisions\/30115"}],"wp:attachment":[{"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/media?parent=30107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/categories?post=30107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mylav.net\/fr\/wp-json\/wp\/v2\/tags?post=30107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}